GT
43
2
ILMN
31
4
OXY
42
17
HUM
25
4
CAT
47
3
PBI
30
-8
EMN
40
5
VFC
56
6
NEE
39
9
NKE
36
2
CMS
57
2
GME
61
2
O
26
16
ZBH
69
15
PHM
44
4
LB
16
9
GS
65
16
ALL
37
3
CVS
27
2
USB
50
3
GT
43
2
ILMN
31
4
OXY
42
17
HUM
25
4
CAT
47
3
PBI
30
-8
EMN
40
5
VFC
56
6
NEE
39
9
NKE
36
2
CMS
57
2
GME
61
2
O
26
16
ZBH
69
15
PHM
44
4
LB
16
9
GS
65
16
ALL
37
3
CVS
27
2
USB
50
3
Financhill
Back

NETLease Corporate Real Estate ETF Vs. Novo Nordisk AS Industry Stock Comparison

Sell
28

NETL
NETLease Corporate Real Estate ETF

Last Price:
$23.31
Seasonality Move:
-12.38%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
28
NETLease Corporate Real Estate ETF (NETL) is a Sell

Is NETLease Corporate Real Estate ETF a Buy, Sell or Hold?

  • The current NETLease Corporate Real Estate ETF [NETL] share price is $23.49. The Score for NETL is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NETL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NETL Stock Price Chart

What is NETLease Corporate Real Estate ETF's stock price today?

  • The NETLease Corporate Real Estate ETF share price today is $23.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NETL is experiencing slight selling pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

NETL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 22.05 Sell
Chaikin Money Flow: -683 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.43 - 25.73) Sell
Bollinger Bands (100): (25.1 - 26.84) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

NETL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.36 Sell
20-day SMA: 25.02 Sell
50-day SMA: 25.55 Sell
200-day SMA: 24.72 Sell
8-day EMA: 24.2 Sell
20-day EMA: 24.77 Sell
50-day EMA: 25.33 Sell
200-day EMA: 25.03 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

NETLease Corporate Real Estate ETF Earnings Growth & NETL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

NETLease Corporate Real Estate ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):